BRISBANE, Calif., Feb. 21, 2019
/PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a
genomic medicine company, announced today that the Company will
release its fourth quarter and full year 2018 financial results
after the market closes on Thursday,
February 28, 2019. The press release will be followed by a
conference call at 5:00 p.m. ET,
which will be open to the public via telephone and webcast. During
the conference call, the Company will review its financial results
and provide a business update.
The conference call dial-in numbers are (877) 377-7553 for
domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 6875578. Participants may
access the live webcast via a link on the Sangamo Therapeutics
website in the Investors and Media section under Events and
Presentations. A conference call replay will be available for one
week following the conference call. The conference call replay
numbers for domestic and international callers are (855) 859-2056
and (404) 537-3406, respectively. The conference ID number for the
replay is 6875578.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
medicines with the potential to transform patients' lives using the
Company's platform technologies in genome editing, gene therapy,
gene regulation and cell therapy. For more information about
Sangamo, visit www.sangamo.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-fourth-quarter-and-full-year-2018-conference-call-and-webcast-300799927.html
SOURCE Sangamo Therapeutics, Inc.